Cytotoxic potential of dihydrochalcones from Eriosema glomeratum and their semi-synthetic derivatives

Nat Prod Res. 2024 Jan-Feb;38(2):186-197. doi: 10.1080/14786419.2022.2111563. Epub 2022 Aug 13.

Abstract

In the search of cytotoxic dihydrochalcones, this investigation led to the isolation of seven compounds (1-7) from Eriosema glomeratum and the preparation of eight derivatives (8-15). The cytotoxicity of samples was evaluated against lung (A549), breast (MCF-7), and cervical (HeLa) human cancer cells. The CH2Cl2/MeOH extract of the aerial part had strong cytotoxicity against all cells [IC50 11.2 (MCF-7), 8.4 (HeLa) and 13.1 (A549) μg/mL]. A strong activity was also displayed by the n-hexane fraction on MCF-7 (IC50 11.2 μg/mL). The precursor 3 and the derivative 8 were specifically found as strong cytotoxic agents toward MCF-7 (7.6 μM) and HeLa (3.1 μM), respectively and were more effective than the positive control. Derivatives 8 (3.1 μM) and 9 (21.3 μM) against HeLa were most potent than their precursor 3 (23.7 μM). This is the first preparation of 8-14 as well as the cytotoxicity of 3, 4, 8-15, fractions, and extract.

Keywords: Cytotoxicity; Eriosema glomeratum; erioschalcones A and B; semi-synthesis.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • HeLa Cells
  • Humans
  • MCF-7 Cells
  • Plant Extracts / pharmacology

Substances

  • dihydrochalcone
  • Antineoplastic Agents
  • Plant Extracts